A NEW MOUSE IMMUNOGLOBULIN: IGG3 by Grey, Howard M. et al.
A  NEW  MOUSE  IMMUNOGLOBULIN:  IGG3* 
BY HOWARD  M.  GREY,:~  M.D.,  JUDITH  WEGMAN HIRST,  PI~.D., 
AND MELVIN  COHN,  P~.D. 
(From the Scripps  Clinic and  Research Foundation,  La Jolla,  California  92032,  and 
the Salk Institute for Biological Studies, San Diego, California 92112) 
(Received for publication 14 Sep~ ~mber 1970) 
A  library of murine Inyeloina tumors was catalogued (1)  with respect to the 
iininunoglobulins they  produced.  Of  161  sera  screened,  19  were  of  the  IgG1 
class,  10 of the IgG2a class,  11  of the IgG2b class,  and 120  of the IgA class.  1 . 
In addition,  we  found one  tumor  (J606)  which  produced  an iinmunoglobulin 
untypable by any of our anti-class sera and which possessed anti-levan activity. 
The purpose of the present study was to characterize this new iininunoglobulin 
with respect  to certain structural and biologic properties. 
Materials and Methods 
Antiseva.--Rabbit  antisera specific for mouse immunoglobulins  were prepared by injection 
of  1-5 mg of the appropriate myeloma protein in complete Freund's adjuvant every 2 wk. 
The resultant antisera were made specific by absorption with myeloma proteins of a different 
class or subclass.  Rabbit anti-J606 Fc antiserum was prepared by absorbing with J606 Fab 
prepared by papain digestion. 
Antigenic Analysis.--Immunodiffusion,  immunoelectrophoresis, and radial immunodiffnsion 
were performed as previously described (2). The immunoelectrophoresis  modification described 
by Osserman (3) was used to identify the J606-1ike compoI~ent in normal mouse serum. 
Isolation.--(a)  The J606 protein was purified from the serum by starch block electrophoresis 
(4). The purity of the isolated protein was determined by immunoelectrophoretic analysis at 
a  concentration of  10-20 mg/ml, using an antiserum prepared against whole mouse serum. 
(b) The J606  protein was also purified by bringing the serum to 30% of saturation with a 
solution of saturated ammonium sulfate, dialyzing against 0.9% NaC1 buffered  with 0.01 ~I 
potassium phosphate buffer (PBS) 2, pH 7.4, reprecipitating with 30% ammonium sulfate, and 
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finally dialyzing against 0.02 g  potassium phosphate buffer, pH 8.0. The J606 protein, which 
precipitates under these conditions, was redissolved in PBS. 
Reduction and Alkylation.--Proteins were partially reduced  and  alkylated  as  previously 
described  (5)  using  0.2 M 2-mercaptoethanol  and  0.3 M recrystallyzed  iodoacetamide.  For 
peptide mapping, alkylation was done with 14C-labeled iodoacetamide. For molecular weights 
and peptide mapping,  the proteins were also completely reduced and alkylated in 8 ~  urea: 
0.1 ~  tris (hydroxymethyl) aminomethane (Tris), pH 8, again using 0.2 ~  2-mercaptoethanol 
and 0.3 M iodoacetamide. H  and L chain separation was accomplished by G-100 gel filtration 
in 1 ~  acetic acid. Molecular weight determinations of fully reduced and alkylated heavy and 
light chains of J606 protein were carried out according to the method described by Andrews 
(6) using a Sephadex G-200 column equilibrated with 8 M urea and 0.05 N propionic acid. 
Enzymatic  Digestion.--Papain  digestion (7) was carried out using 1% w/w papain for 45 
rain at 37°C. Digestion was stopped by the addition of a five-fold molar excess of iodoacetamide 
over the cysteine present in the reaction mixture. The resultant Fc fragment was insoluble and 
was purified by repeated washing with cold PBS at pit 7.0. The Fab was purified by starch 
block electrophoresis. For peptide mapping, trypsin digestion was carried out on completely 
reduced and alkylated H  and L  chains using 1% w/w of TPCK-trypsin  (Worthington Bio- 
chemical Corp.,  Freehold, N. J.)  for 16 hr at 37°C  in 0.1 M ammonium bicarbonate, pH 8. 
The reaction was stopped by lyophilization of the reaction mixture. 
Peptide Mapping and Amino Acid Analyses.--Peptide mapping,  elution of peptides,  and 
analyses of peptides for amino acid coinposition were carried out as previously described (8). 
Amino acid  analyses were  performed  using  a  Beckman  Model  120C  amino  acid  analyzer 
equipped with a  12 cm "short" column which was capable of resolving glucosamine, galactos- 
amine, and tryptophan.  Carboxy-terminal amino acids were determined by  digestion with 
carboxypeptidases A or B  (9) and by hydrazinolysis (10).  Both ~- and "g-chains were used as 
controls. 
Ultracentrifugation.--Analytical  ultracentrifugation was carried out on isolated J606 prepar- 
ations at different protein concentrations using a Beckman model E analytical ultracentrifuge 
equipped with schlieren and interference optics. The sedimentation coefficient of the protein 
was determined by standard procedures  (11).  The molecular weight of freshly isolated J606 
protein was determined by sedimentation equilibrium according to the method described by 
Yphantis (12). The partial specific volume (?)  of the J606 was calculated to be 0.735 on the 
basis of its amino acid composition (13). 
Cyanogen Bromide  Cleavage.--Cyanogen  bromide cleavage was  carried  out  in  70%  v/v 
formic acid for 24 hr at room temperature (14). 
Starch  Gel Electrophoresis.--Vertical  starch gel  electrophoresis was  performed  either by 
employing a 0.05 ~  glycine buffer, pH 8.8  (15), or an acid urea-formate buffer, pH 3.0  (16). 
Acrylam#le  Gd Electrophoresis.--The  procedure  of Sulitzeanu et  al. was used  (17).  Gels 
were run at an acrylamide concentration of 4.5%. 
Skin  Fixation.--Reversed passive  cutaneous  anaphylaxis was  performed  in  guinea pigs 
according to the method of Ovary (18). Anaphylactic shock was examined by injecting BALB/c 
mice with 100 ttg J606 protein intravenously and challenging with an intravenous injection of 
100 #g levan B523 24 hr later. The passive cutaneous anaphylaxis (PCA) test was carried out 
on B ALB/c mice injected intradermally with 1, 10, and i00 #g of J606 protein and challenging 
with an intravenous injection of 10 or 20/tg levan B523 plus  Evans  Blue after 31/~, 4, and 
4}~  hr. The test was read 30-50 min after the injection of the levan. 
Complement Bindlng.--The capacity of unaggregated immunoglobulins to bind the activated 
first component of complement C1 was performed using a modification of the C1 fixation test. 3 
3 Augener, W., and H. M.  Grey. Relationship between immunoglobulin aggregation and 
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Chemicals.--The  levans used in this study were kindly provided by Doctors A. Jeanes and 
E. A. Kabat. Their characteristics are listed in Table I. Iodinated A protein was prepared with 
131I using a modification of the chloramine-T  method (19). Radioactive levan was prepared 
by iodination of the p-hydroxy-benzyl4evan  with 13~I, again using the chloramine-T method. 
The  p-hydroxy-benzyl-levan was  prepared  by conjugating levan B1662 with a-bromo-p- 
nitrotoluene and  subsequently reducing,  diazotizing,  and  hydrolyzing the nitro group  ac- 
cording to the method of Siskind et al. (20). 
RESULTS 
Immunologic  Characterization.--The  J606  protein was  first  identified as  an 
immunoglobulin showing a  reaction on  an Ouchterlony diffusion slide with  a 
TABLE I 
Lcvan  Source  Linkage  Donor 
NRRL B-523; Fraction M  Leuconostoc  mesenteroides  Beta 2-6  EAK, AJ 
(3664-46) 
NRRL B-512; Fraction A  L. mesenteroides  Beta 2-6  EAK, AJ 
(P.P. 2, 3801-30) 
NRRL B-1662; Fraction S  Bacillus sp.  Beta 2-6  AJ 
(4100-77R) 
Inulin  Rye grass  Beta 2-1  Sigma 
Aerobacter levan batch 19  Aerobacter  --  AJ 
FIG. 1.  Cellulose acetate electrophoresis of serum from a mouse carrying the J606 tumor and 
normal mouse serum  (NMS). A homogenous peak in the V2  region is evident in the J606 
serum. 
beta  2-6-1inked  levan.  No  other  myeloma  immunoglobulin  in  our  collection 
showed this reaction. Fig.  1 shows the electrophoretic appearance of the J606 
protein in the serum of mice bearing the J606 tumor. The J606 purified protein 
showed one major band on acrylamide gel electrophoresis (Fig. 2). The purified 
protein  retained  anti-levan  activity.  Diluting  the  protein  revealed  that  the 
band  actually consisted of  a  series  of  two  or  three  closely running  bands  of 
decreasing intensity. All the bands were removed following precipitation of the 
protein with the levan (Fig. 2). 
To determine if normal mouse serum contained a  protein similar to J606,  a 
rabbit antiserum specific for J606 Fc fragment was prepared. When this rabbit 
antiserum was allowed to react with normal mouse  serum following immuno- 292  A  NEW  MOUSE  IMMUNOGLOBULIN: iGo3 
electrophoresis a  distinct cathodal arc was  observed which bore antigenic de- 
terminants  in  common with  the .1606  Fc fragment  (Fig. 3).  When  compared 
with the electrophoretic mobility of mouse IgG1 and IgG2, the J606 component 
FIG. 2.  Acrylamide gel electrophoresis  of the J606  protein purified  by method  (b)  (see 
Materials and Methods). 1. 150 ~g of J606 protein; 2.50 #g of J606 protein; 3.10 #g of J606 
protein; 4. 5 #g of J606 protein; 5. supernatant after precipitation of 500/zg of J606 protein 
with 40/~g of levan B512; 6; supernatant after precipitation of 500 #g of J606 protein with 
20 #g of levan B512. 
FIG. 3.  J606 in normal mouse serum. Immunoelectrophoresis  of NMS reacted against rabbit 
anti-J606 Fc antiserum (lower trough). Purified J606 protein at a concentration of 2 mg/ml is 
in the upper trough. A line of continuity was formed between the J606 protein and the protein 
present in NMS. 
in normal mouse serum moved in the same position as the mouse IgG2 (Fig. 4). 
Radial immunodiffusion analysis indicated that  the concentration of the J606 
protein in normal BALB/c mouse serum was 0.1-0.2 mg/ml. 
The rabbit anti-J606 Fc was also used in Ouchterlony analysis against mye- 
loma proteins representative of the five other mouse immunoglobulins (IgG1, 
IgG2a,  IgG2b,  IgA, and  IgM).  No  precipitin reaction was  seen  (Fig. 5)  nor HOWARD  M.  GREY,  JUDITH  W.  HIRST,  AND  MELVIN  COHN  293 
was there  any inhibition  of the  J606  anti-J606  line with  any of the  proteins 
tested.  The  protein  did,  however,  show  a  reaction  with  antiserum  directed 
toward the kappa light chain. 
The  possibility  was  entertained  that  J606  represented  the  homologue  to 
either  IgD  or IgE,  two human immunoglobulin  classes which have not been 
previously identified  in  the  mouse. Immunodiffusion analysis was performed 
using the  J606  protein  and  rabbit antisera specific for human IgD and  IgE. 
FIG. 4. Electrophoretic mobility of J606-1ike protein in NMS. Immunoelectrophoresis of 
NMS subsequently reacted against antiserum directed toward IgG1 +  IgG2, IgG2, and J606 
Fc. The J606-1ike protein in normal serum has a mobility similar to that of IgG2. 
FIo. 5. Ouchterlony analysis of anti-J606 Fc reacted against IgG1, IgG2a, IgG2b, and 
IgA at a concentration of 1 mg/ml. Lines of precipitation are only seen with the J606 protein 
and extend sharply and undeflected toward the wells containing the other immunoglobulins 
indicating a lack of cross-reaction  with these proteins. There was also no reaction with an IgM 
protein (not shown). 
J606 did not precipitate with either antiserum nor did it inhibit the precipitation 
or IgD  or IgE with  their  respective antisera. 
Physical and Chemical Studies 
(a) Papain Digestion.--As shown in Fig. 6, papain digested the J606 protein 
into two fragments which, when compared by immunodifusion, were non-cross- 
reacting. The slower migrating fragment reacted with a kappa chain antiserum 
and showed anti-levan activity (see below)  and was thereby identified  as the 
Fab fragment. The faster migrating fragment (Fc) was almost totally insoluble 294  A  NEW  MOUSE  IMMLrNOGLOBULIN:  IGG3 
at neutral pH. At a  concentration of 5 mg/ml in PBS at pH7,  less than 5 %  of 
the Fc fragment was soluble. 
(b)  Ultracentrifugal  Analysis.--When  the  J606  protein,  which was pure  as 
judged by antigenic analysis, was analyzed in the ultracentrifuge by sedimenta- 
tion  velocity at  neutral  pH,  an  asymetric  peak  with  a  shelf  of rapidly sedi- 
menting  material  was  obtained  (upper  pattern,  Fig.  7).  One  explanation  for 
this heterogeneity was that the J606 protein had a  tendency to aggregate. To 
FIG. 6.  Papain fragments of J606 protein. Immunoelectrophoresis of the isolated Fab and 
Fc fragments from a papain digest of the J606 protein. The center trough contains an unab- 
sorbed rabbit anti-J606 antiserum. 
FIG. 7.  Ultracentrifuge pattern of J606 protein at a concentration  of 5 mg/ml. Upper pat- 
tern was obtained  when protein was dissolved in PBS, pH 7. The sedimentation  coefficient 
obtained under these conditions was 10.5S. Lower pattern was obtained with protein dissolved 
in 0.1 •  acetate  buffer, pH 4.2. 
evaluate  this  possibility,  a  sedimentation  velocity experiment  was performed 
at  pH 4.2.  Under  these  conditions  a  single  homogeneous peak  was  obtained 
with a sedimentation coefficient of 5.8S (lower pattern,  Fig. 7). 
The formation of noncovalently bound aggregates at neutral pH was further 
confirmed  by  studying  the  concentration  dependency  of  the  sedimentation 
coefficient. Fig. 8 illustrates the s vs. c plot. At pH 4.2 a linear plot was obtained 
with  an  extrapolated  s~o, w value of 6.3S.  In contrast  to this,  at neutral  pH a 
curvilinear plot was obtained.  This  anomalous behavior is typical of a  concen- 
tration-dependent  associating system and is further proof that the J606 protein 
formed noncovalent aggregates with itself. 
Molecular weight determinations  were performed  on the  intact  protein  and HOWARD  M.  GREY,  JUDITH  W.  HIRST,  AND  MELVIN  COHN  295 
Fab fragment  at pH 4.0 by using sedimentation equilibrium. These  data are 
shown in Table II and indicate that the Fab fragment and intact protein have 
molecular weights similar to those of 3'G: 150,000  for the intact protein and 




Acetate, pH  4.~2 
Concentration (mg/ml) 
FIG. 8.  s vs. c plot of J606 myeloma protein in PBS, pH 7, and in 0.1 H acetate buffer, pH 
4.2. 
TABLE II 
Sedimentation Equilibrium Data for J606 Protein and Fab Fragment 
No. of 
Protein  deter-  Protein  mina-  Concentration  v  rprn  Average tool. wt. 
tions 
(mg/ml) 
3  0.2-0.8  0.735  16,200  149,500 
(148,000-152,000) 
2  0.3-0.6  0.730  24,630  47,200 
( 45,500- 48,900) 
J606 intact protein 
J606 Fab 
Samples in 0.22 M acetate buffer, pH 4.0, were run at 20°C in a Spinco Model E Ultra- 
centrifuge equipped with Rayleigh interference optics.  Molecular weights were  calculated 
from the plot of lnc vs. r  2. The values presented are averages of determinations shown. The 
ranges of  values is indicated in parentheses.  Solvent  density was  1.0021. Partial specific 
volume was calculated from amino acid and sugar composition. 
After partial reduction and alkylation, J606 protein could be separated into 
heavy and light chains by gel filtration on G-100 Sephadex in 1 M acetic acid. 
The light chain peak contained 23 %  of the total OD  280  absorbing material. 
Molecular weights  of the  completely reduced  and  alkylated heavy and  light 
chains were obtained by gel filtration on G-200 in 81~ urea- 0.05 M propionic 296  A  NEW  MOUSE  IMMUNOGLOBULIN: IGG3 
acid. Reduced and alkylated 131I-labeled human ~/G was used as a marker. The 
H  and L chains of J606 eluted in identical positions to their human "I'G counter- 
parts and therefore had the same mol wt (H  =  50,000;  L  =  23,000).  These 
tool wt are in accord with the mol wt of 150,000  obtained for the intact protein 
assuming that J606 has a molecular formula of H2L2. 
(c) Peplide Analysis.--Peptide  mapping was performed on partially reduced 
and 14C-alkylated H  and L  chains. The peptide map of light chains revealed a 
pattern consistent with its being a kappa chain. There was a single radioactive 
TABLE III 
-Pc Glycopeptldes of Y606 and Different Mammalian IgG 
Human IgGI-4 (22)* 
Rabbit  (23) 
Mouse ~,2a (24) 
Mouse 3,1 (24) 
j6o6 
CHO 
Phe  I  Phe 





Glx-Asx-(Tyr, Asx, Ser, Thr, Leu)-Arg 
CHO 
[ 
Glu-Gln (Phe, Asx, Ser, Thr) Phe-Arg 
CHO 
I 
(Glu, Glu, Ala, Phe, Asx, Set, Thr, Tyr, Arg) 
* The numbers in parentheses refer to references. 
peptide which was eluted and analyzed for amino acid composition. The com- 
position was CMCys, Glu, Asx, which  again confirmed that this was a kappa 
light chain (21). The peptide map of the H  chains when compared with the H 
chain of a 3'2b and  1 protein showed a distinctive pattern. It was not possible 
to clearly demonstrate any peptide that was shared between the J606 H  chain 
and  that of the "y2b and 3,1  proteins.  Because the glycopeptides appear in a 
characteristic position on the peptide map the spot located in this position was 
eluted from the map and amino acid analysis performed and compared with a 
variety of "},G glycopeptides. As seen in Table III, all Fc fragment glycopeptides 
from  mammalian  TG  that  have  been  analyzed  have  a  very  characteristic 
composition and  sequence.  There  is  a  high  degree  of  homology between  the 
composition of the J606  glycopeptide and  that of other "yG peptides. On  the HOWARD M.  GREY, JUDITH W.  HIRST, AND MELVIN COHN  297 
other hand, analyses of glycopeptides from mammalian 7A, M, D, and E  that 
have been done bear no relationship to the 7G or J606 Fc glycopeptide.  4 
A  further  attempt  to evaluate  the  homology between  J606  and  other  im- 
munoglobulins was made  by examining the  C-terminal region of this protein. 
First,  an attempt was made to isolate the C-terminal octadecapeptide which is 
generated following cyanogen bromide cleavage of 7G from a variety of mam- 
malian species. However, cyanogen bromide treatment of J606 as well as mouse 
72a, 72b, and 71 heavy chains failed to produce a  C-terminal octadecapeptide 
from any of these proteins. 
0D280 OF JG06 PROTEIN AODED-~ 
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FiG. 9.  Precipitation  curve  of J606 protein  purified by Method  (b)  (see Materials  and 
Methods)  versus  two levans, B1662 and inulin. To 0.5 ml of PBS containing the levan was 
added 500 #g of J606 protein in 0.5 ml of PBS with immediate mixing. The tubes were placed 
at 37°C for 60 rain and at 4°C overnight. The tubes were centrifuged at 10,000 g for 15 rain 
and the precipitates  washed twice with PBS diluted  1:1 with water.  Precipitates  were dis- 
solved in 1 ml of 1% acetic acid and the OD2s0  determined. 
Identification  of  the  C-terminal  residue  of  the  heavy chain  was  then  at- 
tempted.  Digestion with carboxypeptidase A  or B  failed to release  any amino 
acid, whereas hydrazinolysis yielded 0.5 mole glycine/mole of H  chain.  These 
data are very similar to those obtained for 7  heavy chains where hydrazinolysis 
identifies a glycine C terminal, but due to the presence of a penultimate proline, 
digestion with carboxypeptidase A  fails to release the C-terminal residue. 
Amino acid composition of the J606 H  chain was in general unremarkable. 
Glucosamine was the only amino sugar found. It was present in slightly lower 
4 Grey, H. M., and C. A. Abel. Unpublished data. 298  A  NEW  MOUSE  IMMUNOGLOBULIN:  IGG3 
amounts  (3  moles/mole H  chain)  than  is present  in  other  ~,G proteins  (25), 
and much lower amounts than reported for  the  other immunoglobulin classes 
where  the  total  carbohydrate  content  is  two  to  four  times greater  than  3'G 
(26).  After  partial  reduction  and  alkylation  there  were  3  carboxymethyl 
cysteines and  after  complete reduction  and  alkylation, there  were  9-10  car- 
boxymethyl cysteines. The value of three labile cysteines per heavy chain is in 
keeping with the peptide mapping where three radioactive spots were obtained 
TABLE  IV 
Per cent inhibition of precipitation 
Concentration 
Fructose  Sucrose  Melezitose*  Raffinose~C 
0.2 ~  19  85  --  -- 
0.02 M  8  36  8  18 
0.002  M  1  --  5  4 
0.0002  M  2  0  0  1 
*Melezitose =  glucose-fructose-glucose. 
*Raffinose =  glucose-glucose-fructose. 
TABLE V 
Concentration (mg/ml) of Mouse [mmunoglobulins in the Newborn* 
J606  yG1  3,G2 (a, b) 
Newborn  0.24  0.09  0.27 
Mother  0.12  0.32  0.94 
N/M  2.0  0.28  0.29 
* Two litters of colostrum-deprived newborn  mice were bled during the first 2 hr of life. 
Maternal blood was obtained within 6 hr of delivery. Quantitation of immunoglobulin  con- 
centrations was  done  by radial immunodiffusion  using  monospecific antisera and suitable 
myeloma proteins as standards. 
from the heavy chain that was partially reduced and labeled with 14C iodoaceta- 
mide. 
Antigen-Antibody Reactions.--A  typical precipitation curve  of the  purified 
protein versus  levan  B1662  is  presented  in  Fig.  9.  Inulin,  a  beta  1-2-1inked 
levan, is also precipitated by the J606 protein but this reaction is very tempera- 
ture sensitive, the precipitate being soluble at 37°C, as well as going into solu- 
tion in antigen excess, unlike the beta 2-6 levan precipitation reaction. 
Sucrose, but not fructose, at a concentration about 1 M will dissolve a levan- 
J606  precipitate.  Formation  of a  J606-1evan  precipitate can  be  inhibited by 
sucrose but only at high concentrations  (Table IV)  and perhaps by raffinose, 
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centrations  as high  as 10-4M  of sucrose failed to detect specific binding of the 
sucrose to the J606 protein. 
Biologic  Activities.--Several  tests  of biologic  activities  associated  with  im- 
munoglobulins  were performed on the J606  protein.  The most striking  results 
were obtained when the placental transfer of this immunoglobulin was examined 
(Table V). Whereas  the  concentration  of IgG1  and IgG2 in the newborn was 
less than 30 %  of that of the maternal serum, the concentration of J606 protein 
in  the  newborn  was twice  that  of the maternal  serum.  No detectable  IgA or 
IgM was present in the newborn serum, in keeping with previous observations 
(27).  That the relatively high concentrations  of J606 in the newborn were due 
TABLE VI 
Biologic Properties of J606 Protein Compared to Other Mouse Immunoglobulins 
J606  IgG1  lgG2  IgA 
Placental transport*  q- -1- -[-  -t-  -t-  0 
Serum half-life in days*, :~  4  4  (2a)5 (2b)2  1 
C[ binding  0  0  -/-  0 
Cytophilic  attachment§  0  0  -t-  0 
Heterologous  PCA  0  0  -b  0 
Homologous PCA][  0  +  0  0 
Reaction with Protein A¶  + (P) **  0  + (I) :~:~  0 
* Morphis and Gitlin, manuscript in preparation. 
Fahey, J. L., and S. Sell. See reference 28. 
§ Measured by Dr. E. R. Unanue as inhibition  of rosette formation using  mouse IgG2 
antibodies  to sheep red blood cells. 
II Kindly performed by Dr. Z. Ovary and Dr. J. J. Munoz. 
¶ Kindly performed by Dr. G. Kronvall. 
** Precipitation of protein A with J606 protein. 
:~:~ Inhibition of precipitation of protein A with human IgG. 
to maternal-fetal transport rather than active production by the newborn was 
indicated by studies of placental transport of radiolabeled J606 protein (Morphis 
and Gitlin, manuscript in preparation).  In this same study Morphis and Gitlin 
demonstrated  that  the  J606  protein  has  a  relatively long serum half-life  of 4 
days. 
Table VI summarizes some of the other biologic data available for the J606 
protein which has been obtained by us and other investigators. Using a sensitive 
test  for  demonstrating  binding  of  Ci  to  immunoglobulins,  J606  protein  was 
incapable of binding Ci. The J606 protein did not inhibit the cytophilic attach- 
ment of mouse IgG2 immunoglobulins  to macrophages.  As yet, in spite of an 
extensive  search,  no  allotypic  markers  have  been  found  for  this  protein  (R. 
Lieberman,  unpublished  results).  We were  unable  to demonstrate  either  ana- ~ 
~  ,1606 
0  Fob 
15  1/-  -'~" 
,.  oj" 
0  ~  ,...-"  J606-BGG 
x  /  ..,,-"  f"  •  • 
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,-  ,o  .^.f  .  _f- 
u 
w  /# _,-'. 
~  5 
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0~.- "~  ,  ~  ~ 
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FIO. 10.  Precipitation curve of J606 and J606 Fab versus 131I levan. To 0.6 ml of PBS con- 
taining 100 Eg of bovine gamma globulin (BGG),  100 #g of J606 protein, or 50 #g of J606 
Fab +  50 #g of BGG was added the 131I levan (3300 cpm//zg) from a solution of 1 mg/ml. 
The tubes were mixed and incubated for 10 rain at 37°C,  then for 60 rain at 4°C. 1.4 ml of 
saturated ammonium sulfate was added with rapid mixing to bring the reaction mixture to 
70% saturation with ammonium sulfate. The tubes were then kept at 4°C for an additional 
30  rain, centrifuged at  10,000 g for 15  rain, and the precipitates counted in a  gamma well 
counter. 
Fla.  11.  Ultracentrifuge sedimentation pattern of J606 Fc at 5 mg/ml, the A protein of 
Staphylococcus  aureus at 4 mg/ml, and a mixture of the two at the same final concentrations 
as that of the unmixed proteins. Due to aggregation, no schlieren pattern was obtained with 
the Fc fragment alone; however, when mixed with protein A, soluble complexes were formed 
as evidenced by the shelf of rapidly sedimenting material obtained with the mixture which was 
not observed with either of the unmixed samples. 
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phylactic shock or passive cutaneous anaphylaxis in BALB/c mice using the 
levan-anti-levan system. Additionally, Doctors Z. Ovary and J. Munoz carried 
out an extensive  investigation of both PCA and delayed PCA and reversed 
PCA  (RPCA)  reactions  in the mouse  and were unable  to demonstrate any 
skin-fixing activity by these procedures. J606 also failed to react in RPCA in 
the guinea pig. 
The J606 protein reacted with staphylococcal protein A, a reaction which in 
humans has been found to be limited to IgG immunoglobulins (29). This inter- 
action is not shown by any of the other mouse immunoglobulins although the 
IgG2 class is able to inhibit the reaction of the A protein with human gamma 
globulin  (30). In contrast to the reactivity of the J606  Fab fragment with 
levan (Fig.  10), protein A reactivity was associated  with the Fc fragment of 
J606.  Ultracentrifuge analysis  indicated this  interaction since  no  complexes 
TABLE VII 
Percent mI after 50% ammonium  sulfate* 
Supernatant  Precipitate 
Fc +  131I-levan  94  6 
Fc +  131I-protein A  59  41 
131Iqevan  99  1 
l~lI-protein A  85  15 
* Components were mixed together and incubated for 10 rain at 37°C. The tubes were then 
cooled and saturated ammonium sulfate was added to bring the tubes to 50% ammonium 
sulfate. Then the tubes were allowed to stand at 4°C for  1-2  hr.  Subsequently they were 
centrifuged at 10,000 g for 15 rain and the supernatants and precipitates were counted. 
were formed upon mixing Fab  and protein A, whereas protein A complexed 
with and solubilized the otherwise insoluble Fc fragment (Fig. 11). The results 
of several  experiments  using 131I-labeled Fab and Fc fragments are  shown in 
Table VII and confirm the data obtained with the ultracentrifuge. The asso- 
ciation of protein A binding  with the Fc fragment rather than with the Fab 
fragment is  in  keeping  with  previous  studies  performed  with  human  IgG 
fragments and protein A (29). 
DISCUSSION 
The present study has characterized certain structural and biologic features 
of a unique mouse myeloma  protein and its  normal serum counterpart. We  have 
concluded from these studies that the protein is a member  of the IgG class and 
represents a new  subclass of IgG  which we propose to call IgG3.  The  major 
features of the structure and biologic properties of this protein which led to this 
conclusion are as follows: (a) The molecular weight of the intact protein and its 
heavy chain are identical to that of IgG and its heavy chain respectively, these 302  A  NEW  MOUSE  IMMUNOGLOBULIN:  IGG3 
values being lower than  the molecular weights  reported for the  other major 
classes of immunoglobulins: IgA, IgM, IgD, and IgE (26). (5) The carbohydrate 
content of the protein is similar to that of the IgG class and is distinctly lower 
than that described for the other immunoglobulin classes.  The composition of 
the Fc glycopeptide is typical of the IgG class and again is distinct from the 
data obtained with other immunoglobulin classes.  (c) The C-terminal residue 
of the heavy chain is glycine which has been reported only in heavy chains of 
the IgG class. The C-terminal residue of IgM and IgA is  tyrosine (9)  and that 
of IgE, lysine. 5 (d) The most striking biologic properties of this protein are also 
associated with the IgG class; namely, placental transport and reactivity with 
staphylococcal protein A,  although  the former can in certain species also be 
associated with IgM (31). 
It is of interest that despite the rather striking structural and biologic features 
of this protein which  identify it with  the  IgG class,  there was  no antigenic 
cross-reactivity between the J606 protein and proteins of other IgG subclasses, 
i.e., ~/2a, T2b, and ~,1. This is in direct contrast to the situation observed in 
humans where there is extensive cross-reactivity between the four TG subclasses. 
This, however, is not a unique situation to the J606 protein, since mouse IgG1 
cross-reacts poorly, if at all,  with IgG2; and in the horse, IgGt,  which on se- 
quence analysis is clearly an IgG subclass, cross-reacts little, if at all, with the 
other IgG subclasses. There is growing evidence that the various IgG subclasses 
in mammals may have evolved after the major mammalian species diverged 
from one another (32, 33) so that both structurally and biologically there would 
be no compelling reason for the  subclasses  of one mammalian  species  to be 
structurally or functionally very closely related to the subclasses of other mam- 
malian species. Following this line of reasoning, the degree of antigenic cross- 
reactivity between subclasses might give information regarding when,  during 
the course of evolution, the subclasses of a given species emerged. The available 
data mentioned above would suggest that mouse subclasses diverged from one 
another earlier than human subclasses and are thereby structurally less similar 
to one another than the human subclasses. Obviously, amino acid sequence data 
will give more precise information regarding this point. 
SUMMARY 
A new subclass of mouse IgG for which we propose the name IgG3 has been 
shown to have a tool wt of 150,000  consistent with an L~H2 structure, and is 
present  in  normal  mouse  serum  at  a  concentration  of  0.1-0.2 mg/ml.  Its 
molecular  weight,  low  carbohydrate content,  glycopeptide analysis,  and  C- 
terminal analysis are all typical of the IgG class. The intact protein had a strong 
tendency to form noncovalent aggregates with  itself which were dissociable in 
acid. Upon papain digestion an Fab fragment of 47,000 mole wt was generated 
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along with an Fc fragment which was insoluble at neutral pH. As for its biology, 
the protein did not fix complement,  was not cytophilic for "yG2 receptor sites 
on macrophages, and did not show passive cutaneous anaphylaxis. It was very 
efficiently transported across the placenta so that its concentration in the new- 
born was twice that in the serum of the mother, compared to the concentration 
of IgG1 and IgG2 proteins which were only present at one-third the concentra- 
tion of that found in the serum of the mother. The Fc fragment of this protein 
reacted  with  and  was solubilized  by the  staphylococcal A  protein  which  also 
precipitated  the  intact  immunoglobulin.  In  addition,  the  myeloma  protein 
which  was  the  prototype for this  "yG subclass  exhibited  binding  activity for 
levan which was localized to the Fab fragment. 
We wish to express our indebtedness to Dr. Allene Jeanes who very generously supplied us 
with a collection of rare carbohydrates for these studies. 
BIBLIOGRAPHY 
1.  Cohn, M. 1967. Natural historyof themyeloma. Cold Spring Harbor Syrup. Quant. 
Biol. 32:211. 
2.  Augener, W., and H. M. Grey. 1970. Studies on the mechanism of heat aggrega- 
tion of human 7G. J. Immunol.  105:1024. 
3.  Osserman, E. F. 1960. A modified technique of immunoelectrophoresis facilitating 
the identification of specific precipitin arcs. J. Immunol. 84:93. 
4.  Kunkel, H. G.  1954. Zone electrophoresis. Methods Biochem. Anal. 1:141. 
5.  Fleischman, J. B., R. H. Payne, and R. R. Porter. 1962. Reduction of 7 globulins. 
Arch. Biochem. Biophys.  (Suppl.  1): 174. 
6.  Andrews, P. 1965. The gel-filtration behavior of proteins related to their molecular 
weights over a wide range. Biochem. J. 96:595. 
7.  Porter,  R.  R.  1959.  The  hydrolysis  of rabbit  7  globulin  and  antibodies  with 
crystaline papain. Biochem. J. 73:119. 
8.  Grey, H. M., and H. G. Kunkel. 1967. Heavy chain subclasses of human 7 globu- 
lin.  Peptide and immunochemical relationships. Biochemistry. 6"2326. 
9.  Abel, C. A., and H. M. Grey. 1967. Carboxy-terminal amin  o acids of 7A and 7M 
heavy chains.  Science  (Washington).  156:1609. 
10.  Press, E. M., P. J. Piggot, and R. R. Porter. 1966. The N- and C-terminal amino 
acid sequences of the heavy chain from a pathological human immunoglobulin 
IgG. Biochem. J. 99:356. 
11.  Schachman,  H.  K.  1959.  Ultracentrifugation  in Biochemistry.  Academic Press, 
Inc., New York. 
12.  Yphantis,  D.  A.  1964. Equilibrium  ultracentrifugation  of dilute solutions.  Bio- 
chemistry. 3:297. 
13.  Cohn, E. J.,  and J.  T.  Edsall.  1943. Proteins, amino acids and peptides  as ions 
and dipolar ions. Reinhold Publishing Co., New York. 
14.  Prahl, J. W.  1967. The C-terminal sequences of the heavy chains of human im- 
munoglobulin G myeloma proteins of differing isotypes and allotypes. Biochem. 
J. 106:1019. 
15.  Fahey, J. L.  1963. Heterogeneity of myeloma proteins. J. Clin. Invest. 49.:111. 304  A  NEW MOUSE  IM~UNOGLOBULIN:  IoG3 
16.  Poulik, M. D. 1960. The use of urea-starch-gel electrophoresis in studies of reduc- 
tive cleavage of a 5"-2 macroglobulin. Biechem. Biophys. Acta. 44:390. 
17.  Sulitzeanu,  D.,  M.  Slavin,  and  E.  Yecheskeli.  1967. Simplified technique  for 
preparative disc electrophoresis. II.  Further improvements in apparatus  and 
some details of performance. Anal. Biochem. 9.1:57. 
18.  Ovary, Z. 1964. In Immunological Methods. J. Ackroyd, editor. Blackwell Scien- 
tific Publications, Oxford, England. 259. 
19.  McConahey, P. J., and F. J. Dixon.  1966. A method of trace iodination of pro- 
teins for immunologic studies. Int. Arch. Allergy A ppl. Immunol. 29:185. 
20.  Siskind, G. W., W. E.  Paul, and B.  Benacerraf.  1967. The use of radioactively 
labeled SIII to study the blood clearance and the immune response of mice to 
pneumococcal polysaccharides. Immunechemistry. 4:455. 
21.  Apella, E., and R. N. Perham. 1967. The structure of immunoglobulin light chains. 
Cold Spring Harbor Syrup. Quant. Biol. 32:37. 
22.  Grey, H. M., and C. A. Abel. 1969.  Subclass and allotype differences in human 
3"G immunoglobulins reflected by the amino acid sequence of Fc glycopeptides. 
In  Protides  of  Biological Fluids.  H.  Peeters,  editor.  Pergamon  Press  Inc., 
New York. 17:229. 
23.  Hill, R. L., R. Delaney, H. E. Lebovitz, and R. E. Fellows, Jr.  1966. Studies on 
the  amino  acid sequence  of heavy chains from  rabbit immunoglobulin IgG. 
Prec. Roy. Soc. Ser. B  Biol. Sci. 166:159. 
24.  Melchers, F., and P. Knopf.  1967. Biosynthesis of the carbohydrate portion of 
immunoglobulin chains: Possible  relation  to  secretion.  Cold  Spring  Harbor 
Syrup. Quant. Biol. 32:255. 
25.  Abel, C. A., H. L. Spiegelberg, and H. M. Grey. 1968. The carbohydrate content 
of fragments and polypeptide chains of human 5"G myeloma proteins of different 
heavy chain subclasses. Biochemistry. 7:1271. 
26.  Cohen, S., and C. Milstein. 1967. Structure and biological properties of immune- 
globulins. Advan. lmmunol. 7:1. 
27.  Fahey, J. L., and W. F. Barth. 1965. The immunoglobulins of mice. 4. Serum im- 
munoglobulin changes following birth. Prec. Soc. Exp. Biol. Med. 118:596. 
28.  Fahey, J. L., and S. Sell. 1965. The immunoglobulins of mice. V. The metabolic 
(catabolic) properties of five immunoglobulin classes. J. Exp. Med. 122:41. 
29.  Forsgren, A., and J. Sjoquist. 1966. "Protein A" from S. aureus I. Pseudo-immune 
reaction with human 3' globulin. J. Immunol. 97:822. 
30.  Kronvall, G., H.  M.  Grey, and R.  C. Williams. 1970.  Protein A reactivity with 
mouse immunoglobulins. Aspects of structural relationship between some mouse 
and human  immunoglobulins. J. Immunol.  105:1116. 
31.  Hemmings, W. A., and R. E. Jones. 1967. The occurrence of macroglobulin anti- 
bodies in maternal and foetal sera of rabbits as determined by gradient centrifu- 
gation. Prec. Roy. Soc. Ser. B. Biol. Sci. 157:27. 
32.  Grey, H. M. 1969. Phylogeny of the immunoglobulins. Advan. Immunol. 10:51. 
33.  Pink,  J.  R.  L.,  S. H.  Battery,  G.  M.  DeVries, and  C.  Milstein.  1970.  Human 
immunoglobulin  subclasses.  Partial  amino  acid  sequence  of  the  constant 
region of a 5'4 chain. Biochem. J. 117:33. 